These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 23742830)
61. Secondary Infections in Febrile Neutropenia in Hematological Malignancies: More Than Another Febrile Neutropenic Episode. Demirel A; Tabak F; Ar MC; Mete B; Öngören Ş; Yemişen M; Özaras R; Eşkazan E; Başlar Z; Mert A; Soysal T; Ferhanoğlu B; Aydın Y; Öztürk R Turk J Haematol; 2015 Sep; 32(3):243-50. PubMed ID: 25913035 [TBL] [Abstract][Full Text] [Related]
62. Soluble urokinase-type plasminogen activator receptor is a novel biomarker predicting acute exacerbation in COPD. Gumus A; Altintas N; Cinarka H; Kirbas A; Hazıroglu M; Karatas M; Sahin U Int J Chron Obstruct Pulmon Dis; 2015; 10():357-65. PubMed ID: 25709430 [TBL] [Abstract][Full Text] [Related]
63. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery. Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975 [TBL] [Abstract][Full Text] [Related]
64. Serum adenosine deaminase and procalcitonin concentrations in neutropenic febrile children with acute lymphoblastic leukaemia. Hitoglou-Hatzi S; Hatzistilianou M; Gougoustamou D; Rekliti A; Agguridaki Ch; Athanassiadou F; Frydas S; Kotsis A; Catriu D Clin Exp Med; 2005 Jul; 5(2):60-5. PubMed ID: 16096855 [TBL] [Abstract][Full Text] [Related]
65. Soluble urokinase-type plasminogen activator receptor as a measure of treatment response in acute exacerbation of COPD. AboEl-Magd GH; Mabrouk MM J Bras Pneumol; 2018; 44(1):36-41. PubMed ID: 29538541 [TBL] [Abstract][Full Text] [Related]
66. Soluble receptor for urokinase plasminogen activator in community-acquired pneumonia in children. Wrotek A; Pawlik K; Jackowska T Adv Exp Med Biol; 2013; 788():329-34. PubMed ID: 23835994 [TBL] [Abstract][Full Text] [Related]
67. Procalcitonin: a useful discriminator between febrile conditions of different origin in hemato-oncological patients? Schüttrumpf S; Binder L; Hagemann T; Berkovic D; Trümper L; Binder C Ann Hematol; 2003 Feb; 82(2):98-103. PubMed ID: 12601488 [TBL] [Abstract][Full Text] [Related]
68. Value of soluble Urokinase plasminogen activator receptor over age as a biomarker of impaired myocardial relaxation. Koh AS; Velmurugan B; Gao F; Tan RS; Wong JI; Teo LLY; Keng BMH; Chua SJM; Yuan JM; Koh WP; Cheung C BMC Geriatr; 2017 Nov; 17(1):275. PubMed ID: 29179674 [TBL] [Abstract][Full Text] [Related]
69. Soluble urokinase plasminogen activator receptor (suPAR) in children with obesity or type 1 diabetes as a marker of endothelial dysfunction: a cross-sectional study. Kostopoulou E; Kalavrizioti D; Davoulou P; Sinopidis X; Papachristou E; Goumenos DS; Dimitriou G; Spiliotis BE; Papasotiriou M Eur J Pediatr; 2024 May; 183(5):2383-2389. PubMed ID: 38448612 [TBL] [Abstract][Full Text] [Related]
70. The Plasma Soluble Urokinase Plasminogen Activator Receptor Is Related to Disease Activity of Patients with ANCA-Associated Vasculitis. Huang F; Li Y; Xu R; Cheng A; Lv Y; Liu Q Mediators Inflamm; 2020; 2020():7850179. PubMed ID: 32322165 [TBL] [Abstract][Full Text] [Related]
71. Serum soluble urokinase-type plasminogen activator receptor as a biological marker of bacterial infection in adults: a systematic review and meta-analysis. Ni W; Han Y; Zhao J; Cui J; Wang K; Wang R; Liu Y Sci Rep; 2016 Dec; 6():39481. PubMed ID: 27991579 [TBL] [Abstract][Full Text] [Related]
72. Predictive value of soluble urokinase plasminogen activator receptor, soluble ST2, and IL-33 in bronchopulmonary dysplasia. Tunc T; Cekmez F; Yildirim S; Bulut O; Ince Z; Saldir M; Aydemir G; Yaman H; Coban A Pediatr Res; 2014 Jun; 75(6):788-92. PubMed ID: 24603291 [TBL] [Abstract][Full Text] [Related]
74. Evaluation of serum procalcitonin, serum interleukin-6, and interleukin-8 as predictors of serious infection in children with febrile neutropenia and cancer. Srinivasan A; Kumar N; Scott JX Indian J Cancer; 2021; 58(2):185-189. PubMed ID: 33402576 [TBL] [Abstract][Full Text] [Related]
76. Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia. Aimoto M; Koh H; Katayama T; Okamura H; Yoshimura T; Koh S; Nanno S; Nishimoto M; Hirose A; Nakamae M; Nakane T; Nakamae H; Kakeya H; Hino M Infection; 2014 Dec; 42(6):971-9. PubMed ID: 25038889 [TBL] [Abstract][Full Text] [Related]
77. Soluble urokinase plasminogen activator receptor associates with higher risk, advanced disease severity as well as inflammation, and might serve as a prognostic biomarker of severe acute pancreatitis. Zhang Q; Li L; Chen H; Zhang G; Zhu S; Kong R; Chen H; Wang G; Sun B J Clin Lab Anal; 2020 Mar; 34(3):e23097. PubMed ID: 31774228 [TBL] [Abstract][Full Text] [Related]
78. Urokinase plasminogen activator receptor and its soluble form in common biopsy-proven kidney diseases and in staging of diabetic nephropathy. Wu CZ; Chang LC; Lin YF; Hung YJ; Pei D; Chu NF; Chen JS Clin Biochem; 2015 Dec; 48(18):1324-9. PubMed ID: 26162494 [TBL] [Abstract][Full Text] [Related]
79. Soluble urokinase-type plasminogen activator levels are related to plasma cytokine levels but have low predictive value for mortality in trauma patients. Timmermans K; Vaneker M; Scheffer GJ; Maassen P; Janssen S; Kox M; Pickkers P J Crit Care; 2015 Jun; 30(3):476-80. PubMed ID: 25721031 [TBL] [Abstract][Full Text] [Related]
80. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Paosong S; Narongroeknawin P; Pakchotanon R; Asavatanabodee P; Chaiamnuay S Int J Rheum Dis; 2015 Mar; 18(3):352-9. PubMed ID: 25469944 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]